Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Gilead Sciences vs. Pfizer


Gilead Sciences (NASDAQ: GILD) and Pfizer (NYSE: PFE) are each in a state of transition. The top executives at Gilead are totally different than they were just one year ago. Pfizer is in the midst of slimming down and narrowing its focus.

Both drugmakers have faced significant headwinds in the last couple of years. However, both also have reasons to be optimistic about the future. Which stock is the better pick now for long-term investors? Here's how Gilead and Pfizer stack up against each other.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
PFE
Share

Comments